Cardinal Health acquisition of The Harvard Drug Group
Acquisition05/06/2015
Cardinal Health announced plans to acquire The Harvard Drug Group from Court Square Capital Partners on June 5, 2015. The acquisition closed on July 2, and the completion release followed July 6. The [figure hidden] purchase was funded with existing cash and new debt. The transaction included two distribution facilities and added generic medicines, over-the-counter products and specialized packaging. Cardinal Health sought greater generics distribution scale, expanded telesales capabilities and broader institutional offerings. Harvard Drug served retail, institutional and alternate-care customers. The strategic acquisition ended Court Square’s private equity ownership and brought the business into Cardinal Health’s pharmaceutical distribution operations.
Type
Acquisition
Announced
05/06/2015
Amount
Financial data requires access
Asset class
Private Equity
Reported parties
Cardinal Health, Inc.; Court Square Capital Partners; The Harvard Drug Group